GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Touchstone International Medical Science Co 688013.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

21.76

+4.97%

Close of 10 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Touchstone International Medical Science Co

Its shares trade on Shanghai under the ticker 688013.SS. It has been listed since 28 September 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥326.7m and net income of CN¥84.1m. At that date it held total assets of CN¥672.9m and shareholders' equity of CN¥565.6m.

Touchstone International Medical Science Co., Ltd. specializes in the development of advanced and innovative surgical devices that enhance clinical performance, mini-mize risk, and improve patient outcomes. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2020-09-28. The firm's products include tubular staplers, endoscopic staplers, linear cutting staplers, purse-string staplers and linear suture staplers. Its products are used in the surgical fields of cardiothoracic surgery, gastrointestinal surgery, hepatobiliary spleen and pancreatic surgery, general surgery and urology. The firm conducts its businesses within the China market and to overseas markets such as Italy, Spain, Austria, Brazil, South Korea, the United Kingdom and Australia.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
28 Sept 2020
Employees
231

Leadership

Pay as last reported

  • Mr. Wangyu ChenChairman of the Board, since 2019CN¥1.1m
  • Ms. Guoyu TianChief Financial Officer, Secretary of the Board, Director, since 2022CN¥106,200
  • Mr. Wangdong ChenGeneral Manager, Director, since 2019CN¥1.1m
  • Ms. Wei LiuDirector
  • Ms. Caihong YangDirectorCN¥50,900
  • Mr. Qingyi YouDirector
  • Mr. Ming FanIndependent DirectorCN¥120,000
  • Mr. Wenlong JinIndependent DirectorCN¥120,000
  • Mr. Zhi'an LuIndependent DirectorCN¥120,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Specializes in advanced surgical devices for clinical performance enhancement
  • Headquartered in Suzhou with 231 employees
  • Products include tubular staplers and endoscopic staplers

Weaknesses

  • Limited to China market and select overseas markets
  • No mention of international expansion beyond current markets
  • No data on market share or competitive positioning

Opportunities

  • Potential growth in overseas markets like Italy and Brazil
  • Expansion into new surgical fields such as urology
  • Increasing demand for innovative surgical devices

Threats

  • Reliance on China market for business operations
  • Competition from other surgical device manufacturers
  • No information on regulatory challenges or product recalls

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.